The slip
PARKINSON RECEIPTno. 5691
21 Oct 2026, 20:46 UTCdopamine neurons, braak
predictionKMT2D in dopamine neurons tracks Braak Lewy-body stage
registeredd10aec582b782666
discovery-0.45 p=0.225 n=9
replication-0.21 p=0.581 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.45, p 0.225)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTbfe34d9b089340d469a509db…
follows 48a7dde26c59…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 5691: KMT2D in dopamine neurons, braak
- power
- full sample -0.44 (p 0.070, n 18), 95% CI -0.75 to +0.04. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.46 (p 0.052, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.56 (p 0.016, n 18). not the mix.
- skeptic
- leave-one-out range -0.56 to -0.37, sign flips 0; without severely affected donors -0.44 (p 0.070, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for KMT2D in dopamine neurons.
case closed: nothing better to follow up.